WebMD Health Corp. (NASDAQ:WBMD) shares dropped 9.5% during trading on Tuesday . The company traded as low as $52.92 and last traded at $53.80, with a volume of 2,958,659 shares trading hands. The stock had previously closed at $59.44.

WBMD has been the topic of a number of recent research reports. SunTrust Banks Inc. raised WebMD Health Corp. from a “neutral” rating to a “buy” rating and upped their price target for the company from $62.75 to $75.00 in a research report on Thursday, May 12th. Vetr raised WebMD Health Corp. from a “hold” rating to a “buy” rating and set a $68.50 price objective on the stock in a report on Monday, May 30th. Citigroup Inc. assumed coverage on WebMD Health Corp. in a report on Monday, April 11th. They set a “neutral” rating and a $62.00 price objective on the stock. Zacks Investment Research cut WebMD Health Corp. from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 6th. Finally, KeyCorp reissued a “buy” rating and set a $74.00 price objective on shares of WebMD Health Corp. in a report on Sunday, May 22nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $65.68.

The company’s 50-day moving average is $60.03 and its 200 day moving average is $59.42. The stock has a market cap of $2.01 billion and a PE ratio of 34.69.

WebMD Health Corp. (NASDAQ:WBMD) last issued its quarterly earnings data on Monday, August 8th. The company reported $0.39 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.01. The firm earned $167.60 million during the quarter, compared to the consensus estimate of $165.46 million. The business’s revenue was up 13.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.32 EPS. Equities research analysts anticipate that WebMD Health Corp. will post $1.84 earnings per share for the current fiscal year.

Other hedge funds have recently modified their holdings of the company. Marshall Wace LLP raised its stake in shares of WebMD Health Corp. by 579.7% in the fourth quarter. Marshall Wace LLP now owns 334,978 shares of the company’s stock valued at $16,179,000 after buying an additional 285,692 shares during the last quarter. Bank of Montreal Can raised its stake in shares of WebMD Health Corp. by 22,828.7% in the fourth quarter. Bank of Montreal Can now owns 109,370 shares of the company’s stock valued at $5,282,000 after buying an additional 108,893 shares during the last quarter. California Public Employees Retirement System raised its stake in shares of WebMD Health Corp. by 2.4% in the fourth quarter. California Public Employees Retirement System now owns 115,156 shares of the company’s stock valued at $5,562,000 after buying an additional 2,700 shares during the last quarter. Finally, New York State Common Retirement Fund raised its stake in shares of WebMD Health Corp. by 4.1% in the fourth quarter. New York State Common Retirement Fund now owns 35,900 shares of the company’s stock valued at $1,734,000 after buying an additional 1,400 shares during the last quarter.

WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications. The WebMD Health Network includes: www.WebMD.com, its primary public portal for consumers and related mobile-optimized sites and mobile apps; www.Medscape.com, its primary public portal for physicians and other healthcare professionals and related mobile services; and other sites through which, the Company provides its branded health and wellness content, tools and services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.